Perfusion systems market seen reaching $2.38B by 2030

The global perfusion systems market is projected to grow from $1.6 billion in 2026 to $2.38 billion by 2030, driven by more complex cardiac surgery, organ transplants and wider use of advanced perfusion technologies. North America led the market in 2025, while organ transplant volume continues to support demand.

Why it matters: - Perfusion systems support blood circulation and oxygenation during surgeries when the heart is temporarily stopped. - Demand tracks with cardiac surgery, organ transplantation and critical care capacity, making the market closely tied to hospital procedure volume and surgical technology investment. - The market’s projected 10.5% CAGR through 2030 signals sustained growth for device makers and healthcare providers using perfusion technology.

What happened: - The perfusion systems market is expected to rise from $1.45 billion in 2025 to $1.6 billion in 2026. - The market is forecast to reach $2.38 billion by 2030. - The projected growth rate from 2026 to 2030 is 10.5% CAGR. - North America held the largest share of the global perfusion systems market in 2025.

The details: - Perfusion systems are medical devices used during surgeries where normal heart function is paused. - The systems help maintain circulation and oxygenation and can temporarily substitute organ functions to keep patients stable. - The historical growth period was driven by more complex cardiac surgeries, higher organ transplant volume, wider adoption of extracorporeal life support programs, greater use of cardiopulmonary bypass devices and stronger critical care infrastructure. - Forward growth is supported by investment in advanced surgical facilities, rising use of portable and modular perfusion devices, expanding organ preservation applications, greater focus on patient safety and treatment outcomes, and ongoing automation in perfusion technologies. - Key trends expected to shape the market include broader adoption of advanced ECMO platforms, increased use of normothermic perfusion techniques, more integration of perfusion monitoring technologies, growth in portable perfusion solutions and stronger organ preservation innovation. - In January 2024, the Organ Procurement and Transplantation Network reported 46,632 organ transplants in 2023, up 8.7% from the prior year. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa, in addition to North America.

Between the lines: - The strongest demand drivers are tied to procedures that depend on reliable organ support, so transplant growth and surgical sophistication can have an outsized effect on market expansion. - The emphasis on portable, modular and automated systems suggests the market is shifting toward devices that can be used in more settings and with less manual oversight. - North America’s lead points to mature healthcare infrastructure and early adoption of advanced medical devices, while other regions may offer future growth as access expands.

What's next: - The market is likely to keep expanding as hospitals invest in advanced surgical capability and organ preservation technologies. - Adoption of ECMO, normothermic perfusion and monitoring tools will be key indicators of where the market is headed. - Continued transplant activity will remain a major demand driver.

The bottom line: - Perfusion systems are moving from a specialized surgical support tool to a market shaped by broader upgrades in transplant care, critical care and automated medical devices. - Download a free sample of the perfusion systems market report - View the full perfusion systems market report